Scott L. Burrows, Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,850 shares at $15.82 ($29K) on 2023-03-02, disclosed to the SEC on 2023-03-02.
Scheduled sale ($29k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.17 | 416 | $7K | 22.9% |
| 2 | $15.82 | 1,416 | $22K | 76.1% |
| 3 | $16.52 | 18 | $297 | 1.0% |
| Total | $15.91 avg | 1,850 | $29K | 100% |
| Filing → |
| SYRE | SELL | 2026-08-05 | $717K | — | Filing → |
| SYRE | SELL | 2026-07-02 | $658K | — | Filing → |
| SYRE | SELL | 2026-06-26 | $1.3M | — | Filing → |